DSpace logo
Please use this identifier to cite or link to this item: http://172.20.40.131:8080/jspui/handle/123456789/80
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDass, Ervilla-
dc.contributor.authorSattigeri, Bhagya Manoj-
dc.date.accessioned2019-06-27T05:32:24Z-
dc.date.available2019-06-27T05:32:24Z-
dc.date.issued2018-01-
dc.identifier.issn2250-1991-
dc.identifier.urihttp://localhost:80/xmlui/handle/123456789/80-
dc.description.abstractLiver is the major organ which helps in detoxifying the drugs; during the process the long standing use of some may cause hepatotoxicity. The NSAIDs are major class, known to cause hepatotoxicity ex; Diclofenac, Sulindac and Aspirin. Hence, Diclofenac sodium was evaluated for its hepatotoxic effect. Albino rats were administered with Diclofenac sodium (72, 96 and 240 mg/kg) respectively as a single oral dose & 24-hours of post-treatment, serum levels of the liver enzymes were evaluated to demonstrate its hepatotoxic effect. Further, the liver was subjected for histopathological study. On statistical analysis Diclofenac had shown significant rise in the levels of serum SGOT & serum SGPT (< 0.05), when compared with the control, which was evident for the hepatotoxic effect of the Diclofenac sodium. It is concluded that, Diclofenac in above mentioned doses has hepatotoxic effect in rats.en_US
dc.language.isoen_USen_US
dc.publisherPARIPEX Indian Journal of Researchen_US
dc.subjectDiclofenacen_US
dc.subjectHepatotoxicityen_US
dc.subjectSerum markersen_US
dc.subjectLiver injuryen_US
dc.subjectNSAIDsen_US
dc.titleDiclofenac Induced Liver Toxicity in Albino Rats: Dose-Dependent Study.en_US
dc.typeArticleen_US
Appears in Collections:Faculty Publications

Files in This Item:
File Description SizeFormat 
1002-3994-1-PB.pdf609.44 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.